Site Map
Contact Us
Home
Home
About Us
Oncology
Infectious Diseases
Contract Manufacturing
Investors
News & Resources
Improving the quality of lives
Site Map
About Us Menu
Management Team
Board of Directors
Medical and Scientific Advisors
Business Development
Collaborations
Careers
Contact Us
Main Menu
Home
About Us
Management Team
Board of Directors
Medical and Scientific Advisors
Business Development
Intellectual Property
Collaborations
Careers
Contact Us
Oncology
Pipeline
Clinical Programs
Bavituximab
Cotara®
Technology Overview
Bavituximab
Cotara®
Preclinical Programs
Anti-Angiogenesis Agents
Vascular Targeting Agents (VTAs)
Infectious Diseases
PS Technology Overview
Biodefense
HCV Clinical Program
Virus Infection Therapy
Topical Microbicides
Vaccine Adjuvants
Protozoan Parasitic Infections
Pipeline
Mechanism of Action
Bavituximab HCV Clinical Program
TMTI Government Contract
Contract Manufacturing
Investors
Investor FAQs
Contact Us
Stock Quote & Chart
Analyst Coverage
SEC Filings
Corporate Governance
News Releases
Annual Reports
Event Calendar
E-mail Alerts
News & Resources
Fact Sheets
News Releases
Upcoming Events
Media Contact
Clinical Menu
Bavituximab
Cotara®
Investigator Sponsored Trial Program
Peregrine Bavituximab and Cotara Clinical Trials
Clinical Pipeline Chart
Clinical Programs
Software Entwicklung Ruhrgebiet
5232373-01.97
© 2003-2010 Peregrine Pharmaceuticals Inc., All Rights Reserved
Disclaimer
|
Safe Harbor